MIR486-2: A Potential Drug Target and Biomarker (G102465696)
MIR486-2: A Potential Drug Target and Biomarker
Mir486-2, a gene expressed in the human placenta, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Its unique expression pattern in different tissues and its involvement in several signaling pathways have made it an attractive target for researchers to investigate.
MIR486-2 is a member of the miRNA-486 family, which is a well-established gene family that has been involved in various physiological processes in humans, including cell growth, differentiation, and survival. The miRNA-486 family has been shown to play a role in the regulation of cellular processes that are relevant to a wide range of diseases, including cancer [2,3].
One of the key functions of miRNA-486-2 is its role in cell proliferation and survival. Studies have shown that MIR486-2 can induce cell proliferation and promote the survival of cancer cells [4,5]. This may contribute to the development of cancer by providing these cells with the resources they need to grow and multiply.
Another function of MIR486-2 is its role in cell adhesion and migration. MIR486-2 has been shown to play a role in the regulation of cell adhesion and in the migration of cancer cells [6,7]. This may contribute to the development of cancer by allowing these cells to spread and establish new tumors.
MIR486-2 has also been shown to be involved in the regulation of cellular signaling pathways that are relevant to a wide range of diseases, including cancer. One of the key signaling pathways that MIR486-2 is involved in is the NF-kappa pathway. NF-kappa is a well-established signaling pathway that is involved in the regulation of cellular processes that are relevant to many diseases, including cancer.
MIR486-2 has been shown to play a role in the regulation of NF-kappa signaling in cancer cells. Studies have shown that MIR486-2 can inhibit the activity of the NF-kappa receptor, which is a key component of the NF-kappa pathway [10,11]. This may contribute to the development of cancer by reducing the signaling pathway that is responsible for cell proliferation and survival.
In addition to its involvement in NF-kappa signaling, MIR486-2 has also been shown to be involved in the regulation of several other signaling pathways that are relevant to a wide range of diseases, including cancer. For example, MIR486-2 has been shown to play a role in the regulation of the PI3K/Akt signaling pathway, the NF-kappa-B signaling pathway, and the NFAT signaling pathway.
MIR486-2 may also be a potential biomarker for a range of diseases, including cancer. The expression of MIR486-2 has been shown to be associated with the development of several types of cancer, including breast, ovarian, and colorectal cancer [15,16]. This may suggest that MIR486-2 may be a useful biomarker for these types of cancer.
In conclusion, MIR486-2 is a gene that has been identified as a potential drug target and biomarker for a wide range of diseases, including cancer. Its unique expression pattern and involvement in several signaling pathways make it an attractive target for researchers to investigate. Further studies are needed to fully understand the role of MIR486-2 in
Protein Name: MicroRNA 486-2
The "MIR486-2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR486-2 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506 | MIR507 | MIR508 | MIR5088 | MIR5089 | MIR509-1 | MIR509-2 | MIR509-3 | MIR5090 | MIR5091 | MIR5092 | MIR5093 | MIR5094 | MIR510 | MIR5100 | MIR511 | MIR511-2 | MIR512-1 | MIR512-2 | MIR513A1 | MIR513A2 | MIR513B | MIR513C | MIR514A1 | MIR514A2 | MIR514A3 | MIR514B | MIR515-1 | MIR515-2 | MIR516A1 | MIR516A2 | MIR516B1 | MIR516B2 | MIR517A | MIR517B | MIR517C | MIR5186 | MIR5187 | MIR5188 | MIR5189 | MIR518A1 | MIR518A2 | MIR518B | MIR518C | MIR518D | MIR518E | MIR518F | MIR5190 | MIR5191 | MIR5192 | MIR5193 | MIR5194 | MIR5195 | MIR5196 | MIR5197 | MIR519A1 | MIR519A2 | MIR519B | MIR519C | MIR519D | MIR519E | MIR520A | MIR520B
